This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Rohit Kumar - Innovator in Pharmaceutical Processes
Introduction
Rohit Kumar is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of complex compounds. His work is characterized by a focus on improving existing processes to enhance efficiency and effectiveness.
Latest Patents
Rohit Kumar holds a patent for a process related to the preparation of remimazolam. This invention pertains to an improved method for synthesizing a compound of formula V or its salts. The patent also outlines a process for preparing a compound of formula I, which is essential in the synthesis of the compound of formula V. This innovative approach showcases his expertise in chemical processes and pharmaceutical development.
Career Highlights
Rohit Kumar is currently employed at Fresenius Kabi Oncology Limited, where he applies his knowledge and skills in the pharmaceutical industry. His role involves working on advanced formulations and processes that contribute to the development of life-saving medications. His dedication to innovation in this field is evident through his patent and ongoing projects.
Collaborations
Rohit collaborates with talented professionals in his field, including Sandeep Dhavaria and Anil Shamraj Bhoyar. These collaborations enhance the research and development efforts at Fresenius Kabi Oncology Limited, fostering an environment of innovation and teamwork.
Conclusion
Rohit Kumar is a distinguished inventor whose work in pharmaceutical processes has made a significant impact. His patent for the preparation of remimazolam exemplifies his commitment to advancing medical science. Through his career at Fresenius Kabi Oncology Limited and collaborations with skilled colleagues, he continues to contribute to the field of pharmaceuticals.
